Fondaparinux indications

Revision as of 19:02, 14 February 2009 by Zorkun (talk | contribs) (Protected "Fondaparinux indications" [edit=sysop:move=sysop])
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Fondaparinux sodium (Arixtra) Injection is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism:

  • in patients undergoing hip fracture surgery, including extended prophylaxis;
  • in patients undergoing hip replacement surgery;
  • in patients undergoing knee replacement surgery;
  • in patients undergoing abdominal surgery who are at risk for thromboembolic complications.

Fondaparinux sodium (Arixtra) Injection is indicated for:

  • the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium, and
  • the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital.